Delving into the Latest Updates on Wenzhou Haihe Pharmaceutical Co Ltd with Synapse

Overview

Tags

Digestive System Disorders

Infectious Diseases

Other Diseases

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Herbal medicine	1

主要目的：以温州海鹤药业有限公司生产的精氨酸布洛芬颗粒（规格：0.6g（以布洛芬计））为受试制剂，以海南赞邦制药有限公司生产的精氨酸布洛芬颗粒（规格：0.6g（以布洛芬计），商品名：司百得®）为参比制剂，比较两种制剂在中国健康成年受试者空腹及餐后状态下的生物等效性。次要目的：观察受试制剂精氨酸布洛芬颗粒和参比制剂司百得®在健康受试者中的安全性。

[Translation]

Primary objective: To compare the bioequivalence of the two preparations in healthy adult Chinese subjects in the fasting and postprandial states, using the arginine ibuprofen granules (specification: 0.6 g (in terms of ibuprofen)) produced by Wenzhou Haihe Pharmaceutical Co., Ltd. as the test preparation and the arginine ibuprofen granules (specification: 0.6 g (in terms of ibuprofen), trade name: Spathik®) produced by Hainan Zanbang Pharmaceutical Co., Ltd. as the reference preparation. Secondary objective: To observe the safety of the test preparation arginine ibuprofen granules and the reference preparation Spathik® in healthy subjects.

Start Date27 Aug 2021

Sponsor / Collaborator

Wenzhou Haihe Pharmaceutical Co Ltd

CTR20210925 / TerminatedNot Applicable

单中心、随机、开放、两周期、交叉设计评价中国健康成年受试者空腹及餐后单次口服0.6g精氨酸布洛芬颗粒的人体生物等效性试验

[Translation] A single-center, randomized, open-label, two-period, crossover design study to evaluate the bioequivalence of a single oral dose of 0.6 g arginine ibuprofen granules in Chinese healthy adult subjects after fasting or after meals

主要目的：以温州海鹤药业有限公司生产的精氨酸布洛芬颗粒（规格：0.6g（以布洛芬计））为受试制剂，以海南赞邦制药有限公司生产的精氨酸布洛芬颗粒（规格：0.6g（以布洛芬计），商品名：司百得®）为参比制剂，比较两种制剂在中国健康成年受试者空腹及餐后状态下的生物等效性。次要目的：观察受试制剂精氨酸布洛芬颗粒和参比制剂司百得®在健康受试者中的安全性。

[Translation]

Primary objective: To compare the bioequivalence of the two preparations in fasting and postprandial state in healthy adult subjects in China, using the arginine ibuprofen granules (specification: 0.6g (in terms of ibuprofen)) produced by Wenzhou Haihe Pharmaceutical Co., Ltd. as the test preparation and the arginine ibuprofen granules (specification: 0.6g (in terms of ibuprofen), trade name: Spathik®) produced by Hainan Zanbang Pharmaceutical Co., Ltd. as the reference preparation. Secondary objective: To observe the safety of the test preparation arginine ibuprofen granules and the reference preparation Spathik® in healthy subjects.

Start Date29 May 2021

Sponsor / Collaborator

Wenzhou Haihe Pharmaceutical Co Ltd

NCT05406050 / CompletedPhase 1IIT

Pharmacokinetic and Bioequivalence Study of Eldecalcitol Soft Capsule 0.75 ug in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Single-center, Single-dose, Open-label, Two-period Crossover Study

A single-center, open-label, randomized, two-period, crossover study design of pharmacokinetics and bioavailability in healthy Chinese subjects under fasting conditions.

Start Date20 Oct 2020

Sponsor / Collaborator

The Affiliated Hospital of Qingdao University

[+1]

100 Clinical Results associated with Wenzhou Haihe Pharmaceutical Co Ltd

Login to view more data

0 Patents (Medical) associated with Wenzhou Haihe Pharmaceutical Co Ltd

Login to view more data

100 Deals associated with Wenzhou Haihe Pharmaceutical Co Ltd

Login to view more data

100 Translational Medicine associated with Wenzhou Haihe Pharmaceutical Co Ltd

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Approval

1

Approved

Login to view more data